Clinical Trial Update: Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

Ongoing Phase 2 clinical trial evaluating pembrolizumab in combination with metformin for metastatic head and neck squamous cell carcinoma; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• metformin (metformin)

Snippet

Sponsor: Trisha Wise-Draper | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING